PerkinElmer has signed an agreement to acquire life sciences firm Covaris, which will expand its life sciences portfolio and provide entrance into the high-growth diagnostics end market.
Both companies are majority owned by New Mountain Capital, a New York-based investment firm; financial and other terms of the transaction were not disclosed.
New Mountain Capital acquired the applied, food, and enterprise services businesses of PerkinElmer in March; its former life sciences and diagnostics divisions rebranded as Revvity.
PerkinElmer is a global analytical services and solutions provider serving the biopharma, food, environmental, safety and applied end markets, with a portfolio that includes atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents.
Woburn, MA-based Covaris develops instruments, consumables, and reagents for high-throughput genomic and proteomic analysis.
